节点文献

一次性腹腔温热灌注化疗在进展期胃癌术中的应用

Treatment of adranced gastric carcinoma with intraoperative intraperitoneal hyperthermochemotherapy

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 吴林生吕自峰郭德鸿毛成艮郭运保

【Author】 WU Lin sheng, LU Zi feng, GUO De hong, MAO Cheng yin, GUO Yun bao (Department of Surgery, People’s Hospital of Linying County, Linying, Henan 462600, China)

【机构】 河南省临颖县人民医院外科!河南临颖462600

【摘要】 目的 探讨在进展期胃癌根治术中一次性腹腔温热灌注化疗的治疗作用。方法 对术中行一次性腹腔温热灌注化疗的 30例进展期胃癌患者与未行此方法治疗的 15例患者的腹腔游离癌细胞检出率及预后等进行对比研究。结果 治疗组引流液中腹腔游离癌细胞检出率为 6 7% ,对照组为 33 3 % (P <0 .0 1)。治疗组 3 ,5年生存率分别为 6 0 %和46 7% ,对照组为 2 6 %和 13 3 % (P <0 .0 1)。结论 一次性腹腔温热灌注化疗具有杀灭腹腔游离癌细胞的作用 ,可改善进展期胃癌的预后

【Abstract】 Objective To investigate the effect of intraoperative intraperitoneal hyperthermochemotherapy(IOIPHTC) in treating advanced gastric carcinoma(AGC). Methods The rates of isolated cancer cells detected in peritoneal fluid and patients’ prognosis were compared between 30 cases of AGC underwent IOIPHTC and 15 cases of AGC without IOIPHTC(control group). Results Postoperatively isolated cancer cell was 6.7% in detected peritoneal fluid in IOIPHTC group; while isolated cancer cells could be detected in up to 33.3% in peritoneal fluid in control group(P<0.01). The 3 ,5 year survival rate in IOIPHTC group was 60% and 46.7%, in control group 26% and 13.3%(P<0.01) respectively. Conclusions IOIPHTC can kill isolated intraperitoneal cancer cells and improve the prognosis of AGC.

  • 【文献出处】 中国普通外科杂志 ,CHINESE JOURNAL OF GENERAL SURGERY , 编辑部邮箱 ,2000年04期
  • 【分类号】R735.2
  • 【被引频次】11
  • 【下载频次】22
节点文献中: 

本文链接的文献网络图示:

本文的引文网络